$7.70
+0.0800 (+1.05%)
At Close: Jul 31, 2026
Tvardi Therapeutics Selects Ulcerative Colitis as Initial Indication for TTI-109
07:30am, Thursday, 30'th Jul 2026
STAT3 acts as a convergent node downstream of multiple signaling pathways implicated in ulcerative colitis (UC), integrating immune dysregulation, inflammation and tissue remodeling
Tetra Technologies (TTI) to Report Q2 Results: What to Know Ahead of the Release
11:06am, Tuesday, 28'th Jul 2026
Tetra Technologies (TTI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
TETRA TECHNOLOGIES, INC. ANNOUNCES DATE FOR SECOND QUARTER 2026 EARNINGS CONFERENCE CALL
04:00pm, Monday, 13'th Jul 2026
SPRING, Texas, July 13, 2026 /PRNewswire/ -- TETRA Technologies, Inc. (NYSE:TTI) will release Second Quarter 2026 results after the market closes on August 3, 2026 and will host a conference call to d
Thiogenesis Receives FDA Rare Pediatric Disease Designation for TTI-0102 for the Treatment of Leigh Syndrome
06:00am, Monday, 13'th Jul 2026
San Diego, California--(Newsfile Corp. - July 13, 2026) - Thiogenesis Therapeutics, Corp. (TSXV: TTI) (OTCQX: TTIPF) ("Thiogenesis" or the "Company"), a clinical-stage biotechnology company developing
Tvardi Therapeutics, Inc. (TVRD) Discusses Phase 1 Data on TTI-109 STAT3 Inhibitor Highlighting Prodrug Design, Tolerability and Target Engagement Transcript
TTI-109 delivered TTI-101-equivalent exposure with improved tolerability and meaningful reductions in disease-relevant STAT3-driven immune cell populations including Th17, T follicular helper (Tfh) an
Tetra Technologies (TTI) Soars 6.6%: Is Further Upside Left in the Stock?
03:10pm, Monday, 29'th Jun 2026
Tetra Technologies (TTI) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near
TETRA TECHNOLOGIES INTRODUCES TETRA NEPTUNE Z-LITE DEEPWATER COMPLETIONS FLUID
07:00am, Monday, 29'th Jun 2026
Using Neptune Chemistry to Achieve Required Density With Lower Zinc Content; Awarded Three-Well 20k psi Deepwater Project in the Gulf of America With Estimated Start in 2026 SPRING, Texas, June 29, 2
TETRA Technologies, Inc. (TTI) Presents at J.P. Morgan Natural Resources Conference 2026 Transcript
01:32pm, Wednesday, 24'th Jun 2026
TETRA Technologies, Inc. (TTI) Presents at J.P. Morgan Natural Resources Conference 2026 Transcript
Thiogenesis Appoints Dr. Gilad Aharon to Its Board of Directors
08:00am, Wednesday, 17'th Jun 2026
San Diego, California--(Newsfile Corp. - June 17, 2026) - Thiogenesis Therapeutics, Corp. (TSXV: TTI) (OTCQX: TTIPF) ("Thiogenesis" or the "Company"), a clinical-stage biotechnology company developing
Can Viavi's New TETRA Testing Upgrade Strengthen Its Growth Story?
10:26am, Tuesday, 16'th Jun 2026
VIAV's new TETRA testing upgrade for the CX300 aims to speed deployments, cut costs, and reinforce its position in mission-critical radio testing.
VIAVI Launches TETRA MS Base Station Simulator Option for CX300 to Simplify and Speed Mission-Critical Radio Testing
06:30am, Monday, 15'th Jun 2026
Allows full testing of TETRA MS radios, including transmitter parametric measurements, call processing and BER/MER loopback without the need to place radios in T1 test mode CHANDLER, Ariz., June 15, 2
Is TETRA Technologies a Buy After An Insider Bought 22,000 Shares?
11:51am, Saturday, 13'th Jun 2026
Hallead acquired 22,000 shares on June 9, 2026, at a weighted average price of $9.86 per share, representing a transaction value of ~$217,000. This purchase increased his direct ownership by 14.79%, b
Thiogenesis Closes Oversubscribed Non-Brokered Private Placement for Gross Proceeds of C$9.07 Million
06:00am, Wednesday, 03'rd Jun 2026
San Diego, California--(Newsfile Corp. - June 3, 2026) - Thiogenesis Therapeutics Corp. (TSXV: TTI) ("Thiogenesis" or the "Company"), a clinical-stage biotechnology company developing a next-generatio
TETRA Technologies, Inc. Announces Pricing of Public Offering of Common Stock
12:00am, Wednesday, 03'rd Jun 2026
TETRA Technologies, Inc. Announces Pricing of Public Offering of Common Stock PR Newswire SPRING, Texas, June 2,
Sign In
Buy TTI